Amerant Bancorp Inc. (AMTB)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	628.86	565.99	296.02	248.44	274.21	214.39
Investment Securities	1,791	23.58	286.12	1,078	1,177	1,251
Trading Asset Securities	163.93	48.01	59.93	78.25	21.87	39.72
Mortgage-Backed Securities	-	1,417	1,161	242.1	118.18	58.13
Total Investments	1,955	1,489	1,507	1,398	1,317	1,349
Gross Loans	7,183	7,228	6,873	6,857	5,409	5,842
Allowance for Loan Losses	-86.52	-84.96	-95.5	-83.5	-69.9	-110.9
Net Loans	7,097	7,143	6,778	6,774	5,340	5,731
Property, Plant & Equipment	134.1	131.84	162.09	181.76	179	109.99
Goodwill	19.19	19.19	19.19	19.51	19.51	19.51
Loans Held for Sale	6.07	42.91	391.42	62.44	158.1	-
Accrued Interest Receivable	102.24	110.49	173.9	67.95	58.77	51.72
Restricted Cash	7.98	24.37	25.85	42.16	-	-
Long-Term Deferred Tax Assets	50.97	53.54	55.64	48.7	11.3	11.69
Other Real Estate Owned & Foreclosed	15.39	18.07	20.18	-	9.72	0.43
Other Long-Term Assets	316.42	303.32	286.64	285.29	271.14	282.56
Total Assets	10,335	9,902	9,716	9,128	7,638	7,771
Accounts Payable	91.13	76.74	75.54	54.31	52.61	41.64
Interest Bearing Deposits	6,600	5,079	5,163	4,748	3,607	3,604
Institutional Deposits	-	1,270	1,305	928.42	840.45	1,256
Non-Interest Bearing Deposits	1,707	1,505	1,427	1,368	1,183	872.15
Total Deposits	8,307	7,855	7,895	7,044	5,631	5,732
Short-Term Borrowings	44.6	512.62	694.43	77.16	552.2	571.43
Current Portion of Long-Term Debt	-	-	-	304.82	-	-
Current Portion of Leases	-	3.8	3.8	5.2	6.4	-
Other Current Liabilities	-	23.5	25	41.6	-	-
Long-Term Debt	29.71	89.47	88.98	88.49	58.89	58.58
Federal Home Loan Bank Debt, Long-Term	765	280	10	601.67	279.58	520
Long-Term Leases	109.23	106.07	123.17	140.15	136.6	-
Trust Preferred Securities	64.18	64.18	64.18	64.18	64.18	64.18
Other Long-Term Liabilities	-	0.3	0.3	0.3	25.2	-
Total Liabilities	9,410	9,011	8,980	8,422	6,807	6,987
Common Stock	4.17	4.21	3.36	3.38	3.59	3.79
Additional Paid-In Capital	336.02	343.83	192.7	194.69	262.51	305.57
Retained Earnings	609.54	582.23	610.8	590.38	553.17	442.4
Comprehensive Income & Other	-25.45	-39.81	-70.8	-80.64	15.22	31.66
Total Common Equity	924.29	890.47	736.07	707.82	834.48	783.42
Minority Interest	-	-	-	-2.09	-2.61	-
Shareholders' Equity	924.29	890.47	736.07	705.73	831.87	783.42
Total Liabilities & Equity	10,335	9,902	9,716	9,128	7,638	7,771
Total Debt	1,013	1,056	984.56	1,282	1,098	1,214
Net Cash (Debt)	-219.93	-442.13	-628.6	-954.97	-801.76	-960.08
Net Cash Per Share	-5.51	-12.37	-18.67	-27.97	-21.36	-23.00
Filing Date Shares Outstanding	41.71	41.88	33.45	33.54	34.4	37.82
Total Common Shares Outstanding	41.71	42.09	33.45	33.52	35.65	37.63
Book Value Per Share	22.16	21.16	22.00	21.12	23.41	20.82
Tangible Book Value	903.39	871.27	716.88	688.31	814.98	763.92
Tangible Book Value Per Share	21.66	20.70	21.43	20.53	22.86	20.30

Updated May 2, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q